| Name | Title | Type |
|---|---|---|
| Yumiko Molden | Chief Financial Officer | Auditee |
| Ryan Iwane | Senior Manager | Auditee |
| James Lacroix | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 372114 | 2024 | 2025-11-13 | COHNREZNICK LLP | $2.25M |
| 363175 | 2023 | 2025-07-28 | Cohnreznick LLP | $2.59M |
| 333215 | 2022 | 2024-12-17 | N&k CPAS INC | $2.72M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 372114 | 2024 | 2025-11-13 | 1162293 | 2024-006 | Material Weakness | Yes | L |
| 372114 | 2024 | 2025-11-13 | 1162292 | 2024-005 | Material Weakness | Yes | I |
| 372114 | 2024 | 2025-11-13 | 1162291 | 2024-004 | Material Weakness | Yes | A |
| 372114 | 2024 | 2025-11-13 | 1162290 | 2024-003 | Material Weakness | Yes | N |
| 372114 | 2024 | 2025-11-13 | 1162289 | 2024-006 | Material Weakness | Yes | L |
| 372114 | 2024 | 2025-11-13 | 1162288 | 2024-005 | Material Weakness | Yes | I |
| 372114 | 2024 | 2025-11-13 | 1162287 | 2024-004 | Material Weakness | Yes | A |
| 372114 | 2024 | 2025-11-13 | 1162286 | 2024-003 | Material Weakness | Yes | N |
| 363175 | 2023 | 2025-07-28 | 1148504 | 2023-004 | Significant Deficiency | - | N |
| 363175 | 2023 | 2025-07-28 | 1148503 | 2023-003 | Significant Deficiency | - | A |
| 363175 | 2023 | 2025-07-28 | 1148502 | 2023-004 | Significant Deficiency | - | N |
| 363175 | 2023 | 2025-07-28 | 1148501 | 2023-003 | Significant Deficiency | - | A |
| 363175 | 2023 | 2025-07-28 | 1148500 | 2023-004 | Significant Deficiency | - | N |
| 363175 | 2023 | 2025-07-28 | 1148499 | 2023-003 | Significant Deficiency | - | A |
| 363175 | 2023 | 2025-07-28 | 572062 | 2023-004 | Significant Deficiency | - | N |
| 363175 | 2023 | 2025-07-28 | 572061 | 2023-003 | Significant Deficiency | - | A |
| 363175 | 2023 | 2025-07-28 | 572060 | 2023-004 | Significant Deficiency | - | N |
| 363175 | 2023 | 2025-07-28 | 572059 | 2023-003 | Significant Deficiency | - | A |
| 363175 | 2023 | 2025-07-28 | 572058 | 2023-004 | Significant Deficiency | - | N |
| 363175 | 2023 | 2025-07-28 | 572057 | 2023-003 | Significant Deficiency | - | A |